#AntiTNF
Sans compter la probabilité de développer des anticorps... contre ces anticorps, ce qui rendrait leur durée d'efficacité assez limitée, comme pour les antiTNF des rhumatismes inflammatoires chroniques.
October 27, 2023 at 11:43 AM
D'avancées médicales susceptibles de faire baisser/limiter l'aspect invalidant. Déjà l'apparition des ttt antitnfα a radicalement changé ma vie. Mon corps est toujours dysfonctionnel, mais nettement moins douloureux et ça ralentit les soudures d'articulations.
July 22, 2025 at 12:40 AM
High Circulating Ki67+ memory T cells (these are fairly clonal by TCR seq) predict non-response to Vedolizumab in #IBD - might be better off going with antiTNF or antiIL23 in these cases
www.sciencedirect.com/science/arti...
Multimodal Profiling of Peripheral Blood Identifies Proliferating Circulating Effector CD4+ T Cells as Predictors for Response to Integrin α4β7–Blocking Therapy in Inflammatory Bowel Disease
Despite the success of biological therapies in treating inflammatory bowel disease, managing patients remains challenging due to the absence of reliab…
www.sciencedirect.com
February 13, 2025 at 12:55 PM
Wish I could! I’m in the business of getting all the vaccines I can (I lost count of COVID shots at 8? 9? and I’ve had the flu shot every year of my adult life).

But MMR is live and I’m on antiTNF…which makes it a hard no.
March 28, 2025 at 6:49 AM
#Pelvisclub

Idem antiTNF alpha mais depuis 2012 humira puis amgevita pour faire des économies à l’APHP, ça commence à moins être efficace...
May 25, 2026 at 7:43 AM
Me rappeller mon traitement antiTNF alpha à 1200€ par mois... on est passé sur 400€ en bio équivalent assez rapidement ( 7 ans de mémoire)
June 12, 2026 at 8:52 PM
As we use UPA in Spain after failure at least to biosimilar antiTNF then often these are refractory patients and we need extended inductions too 😓
February 2, 2025 at 12:39 PM
Clusters of antibiotic use patterns after the first episode of pouchitis

4⃣ groups: rare intermittent > intermittent > chronic antibiotic-responsive > chronic antibiotic dependent

antiTNF prior IPAA & antibióticos in the 12 months prior pouch formation associated with chronic pouchitis

#ECCO2025
February 22, 2025 at 7:58 PM
Mon fils et ma femme servent de diversion 👀

En vrai une piqûre de moustique me fait un œuf de pigeon. Pourtant je ne suis pas immunodeprimé par les antiTNF alpha mais ça doit jouer un peu quand même 😅
June 3, 2025 at 8:16 AM
Alors, ici on n'a même pas abordé le sujet.

J'utilise des antiTNF alpha, donc immunodépresseur, mais comme c'est aussi un traitement utilisé contre le rhumatisme pso, no se.

Je fais grippe/covid et les classiques DTP.

Par contre suivi dermato stricte annuel.
October 10, 2025 at 2:09 PM
Les autres années j'étais comme toi (avec les mêmes précautions, antitnf oblige), et cette année j'ai pris la crème solaire de chez Lidl : non seulement la composition est top, mais en plus elle fonctionne pour de vrai... 🤷🏻‍♂️ Aucun coup de soleil, ni même rougeur...
(Et 7€... 🤷🏻‍♂️)
August 12, 2025 at 8:04 PM
Researchers have created a detailed #CellMap of #childhood #CrohnsDisease before and after treatment, which suggests #AntiTNF therapy might push the pediatric cell ecosystem towards more resistant disease.
#GutHealth #IBD
Single cell map helps predict childhood Crohn’s disease severity and treatment response – BioNews Central
Researchers have created a detailed map of childhood Crohn’s disease before and after treatment which suggests anti-TNF therapy might push the pediatric cell ecosystem towards more resistant disease. ...
sbee.link
September 5, 2026 at 12:24 PM
#Risankizumab results in greater improvements in quality of life and #CrohnDisease symptoms than #ustekinumab among patients with prior #AntiTNF failure. #GastroSky

@brucesands-ibd.bsky.social
Risankizumab Leads to Better Quality of Life Than Ustekinumab in Crohn Disease
Risankizumab improves quality of life, symptom burden, and patient-reported outcomes more than ustekinumab in CD with prior anti-TNF failure.
www.gastroenterologyadvisor.com
June 17, 2026 at 7:42 PM
If using targeted approach, need fuller understanding of risk factors than just ethnicity/place of birth. Average orthopaedic surgeon not trained to think about exposure at any time in life, living in high incidence area (not just born there), prison, antiTNF Rx, occupational exposure, etc.
October 17, 2024 at 7:06 PM
Et sinon un antiTNF pour le nez qui coule c pas possible ? #RhumeDhomme
December 10, 2025 at 1:36 PM
From @umich.edu and @ucsdhealthsci.bsky.social 🦴

Among adults aged 66 years and older with #RheumatoidArthritis, #AntiTNF de-escalation is frequently followed by re-escalation in routine practice, highlighting challenges in sustaining reduced #BiologicTherapy. #RheumSky
Re-Escalation of Anti-TNF Therapy Is Common in Older Adults With RA
Re-escalation of anti-TNF therapy is common among older adults with RA and typically occurs within 6 months of prior de-escalation.
www.rheumatologyadvisor.com
June 16, 2026 at 7:15 PM
“Anti-TNFα as an Adjunctive Therapy in Pancreas and Kidney Transplantation”

Read more: bit.ly/4kV8bvi

#pancreas #kidney #transplantation #antiTNF #TNF #immunosuppressive #therapy
@esottransplant.bsky.social
March 23, 2025 at 3:31 PM
È ACCADUTO IERI: Farmaceutica, Golotta (AbbVie): "Oltre 20 anni in gastroenterologia e Mici con anti-Tnf" ... LEGGI TUTTO #Farmaceutica #Gastroenterologia #MICI #AntiTNF #RicercaMedica
Farmaceutica, Golotta (AbbVie): "Oltre 20 anni in gastroenterologia e Mici con anti-Tnf"
(Adnkronos) - "L'impegno di AbbVie in gastroenterologia è di lunghissima durata. E' un impegno più che ventennale. E' iniziato con l'evoluzione dei trattamenti sulle malattie infiammatorie croniche" grazie alla ricerca "sull'importanz...
dlvr.it
June 28, 2025 at 4:37 PM
Farmaceutica, Golotta (AbbVie): "Oltre 20 anni in gastroenterologia e Mici con anti-Tnf" ... LEGGI TUTTO #Gastroenterologia #MICI #Farmaceutica #Antitnf #RicercaMedica
Farmaceutica, Golotta (AbbVie): "Oltre 20 anni in gastroenterologia e Mici con anti-Tnf"
(Adnkronos) - "L'impegno di AbbVie in gastroenterologia è di lunghissima durata. E' un impegno più che ventennale. E' iniziato con l'evoluzione dei trattamenti sulle malattie infiammatorie croniche" grazie alla ricerca "sull'importanz...
dlvr.it
June 27, 2025 at 1:35 PM